Maria Belousova
About Maria Belousova
Maria Belousova serves as the Analytical Development Molecular Biology Group Lead at Asklepios BioPharmaceutical, Inc. since 2019, bringing extensive experience in technical expertise and protocol development from her previous roles in biotechnology.
Work at Asklepios BioPharmaceutical
Maria Belousova has served as the Analytical Development Molecular Biology Group Lead at Asklepios BioPharmaceutical, Inc. (AskBio) since 2019. In this role, she has contributed to the development of analytical methodologies and strategies. Her responsibilities include providing technical expertise during Deep Dive meetings, CMC meetings, and Comparability studies. Belousova's work supports the advancement of various programs within the company, ensuring alignment with strategic goals.
Previous Experience at BioGX
Before joining Asklepios BioPharmaceutical, Maria Belousova worked at BioGX from 2012 to 2022 as a Managing/Senior Scientist. During her tenure, she focused on molecular biology and analytical development, contributing to the company's research initiatives. Her experience at BioGX spanned a decade, where she gained significant expertise in the field.
Experience at Agenta Biotechnologies
Maria Belousova began her career in the biotechnology sector at Agenta Biotechnologies, where she worked as a Research Scientist from 2010 to 2012. This role provided her with foundational experience in molecular biology and research methodologies, contributing to her professional development in the field.
Education and Expertise
Maria Belousova possesses a strong background in molecular biology and analytical development. Her expertise is demonstrated through her authorship of technical protocols and reports that aid in decision-making processes and strategy alignment at AskBio. Her technical knowledge and experience in the biotechnology industry enhance her contributions to the field.